COTA blog

Research and Technology

Does Using RWE in COVID-19 Research Eliminate the Barrier of Time? Two Data Scientists Explain

June 17, 2020
COTA Team

To further explain COTA’s in-depth analysis and research methods from this ongoing work, Kathryn Tanenbaum, Senior Manager of Operations at COTA spoke with two of our data experts leading COTA’s analysis, Eric Hansen, director of analytics, and Shivam Mathura, director of product and strategy.

READ MORE
Company News

COTA Supports FDA Assessment of Real-World Data through Membership in COVID-19 Evidence Accelerator

June 10, 2020
COTA Team

Leveraging its past knowledge of real-world evidence applications and learnings, COTA has joined the COVID-19 Evidence Accelerator program, a joint initiative of Friends of Cancer Research (Friends) and the Reagan-Udall Foundation for the Food and Drug Administration. Through this initiative, COTA is delivering findings from its observational, real-world studies using data from over 3,000 patients hospitalized with COVID-19 within the Hackensack Meridian Health network.

READ MORE
Company News

Real-World Evidence Provides Insights Into the Effectiveness of Hydroxychloroquine and Tocilizumab for Treating COVID-19 – New Findings Published

June 1, 2020
COTA Team

COTA, in collaboration with Hackensack Meridian Health and Berry Consultants, recently conducted a study using real-world data from more than 3,000 patients hospitalized with COVID-19. The study concluded hydroxychloroquine does not improve survival for patients hospitalized with COVID-19. It was also found that another drug, tocilizumab, may improve survival among critically ill intensive care unit patients.

READ MORE
Company News

COTA, Inc. Announces Participation in the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program and DIA 2020 Virtual Global Annual Meeting

May 29, 2020
COTA Team

COTA, Inc., is pleased to announce its involvement and participation in two industry leading conferences - the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program and the DIA 2020 Virtual Global Annual Meeting. Collectively, the involvement at these two premier events further underscores the importance of RWD’s role in clinical research and oncology care delivery.

READ MORE
Company News

2020 MedTech Breakthrough Awards Recognize COTA as the Best Overall Medical Data Solution Provider

May 18, 2020
COTA Team

COTA, Inc. is pleased to announce that MedTech Breakthrough has named COTA as a winner in the fourth annual MedTech Breakthrough Awards program for the “Best Overall Medical Data Solution Provider" award.

READ MORE
Company News

COTA Participates in Reagan-Udall Foundation + Friends of Cancer Research COVID-19 Evidence Accelerator

May 13, 2020
COTA Team

COTA is actively participating in this collaboration, presenting key findings from ongoing research with Hackensack-Meridian Health involving observational, real-world studies of more than 3,000 hospitalized COVID-19 patients.

READ MORE
Culture

Celebrating the Nurses at COTA During National Nurses Week

May 6, 2020
COTA Team

In recognition of National Nurses Week, we’ve asked COTA’s nurses a few questions about their motivation for becoming a nurse, how their current roles in healthcare technology differs from their experience working in the hospital, and their message to nurses currently on the frontlines of the pandemic.

READ MORE
Company News

COTA Collaborates to Understand COVID-19 Using Real-World Evidence - New Findings Published

May 1, 2020
COTA Team

COTA has partnered with Hackensack Meridian Health (HMH), New Jersey’s largest and most comprehensive health network, and Berry Consultants to conduct an observational real world study of more than 3,000 hospitalized COVID-19 patients.

READ MORE
Company News

Dr. Ming He Joins COTA as Senior Medical Director

April 28, 2020
COTA Team

Today, we are excited to announce the newest addition to our team: Dr. Ming He, COTA’s Senior Medical Director. At COTA, Dr. He will work across the organization, applying her clinical oncology expertise to support various teams including abstraction operations, engineering, product, and analytics.

READ MORE
Culture

COTA Team Member Spotlight: Chew Lee

April 21, 2020
COTA Team

For our April Team Member Spotlight, we are excited to recognize Chew Lee, a Software Engineer on COTA’s engineering team. In addition to his official role as a Software Engineer, Chew also holds the position of being COTA’s Chief Celebration Officer, a role that has become increasingly important as the company adjusts to a completely remote work environment.

READ MORE
Company News

COTA, Inc. named a 2020 Fast 50 company by Boston Business Journal

April 16, 2020
COTA Team

The Boston Business Journal has named COTA, Inc. to its exclusive 2020 Fast 50 list, which represents the 50 fastest-growing private companies in Massachusetts.

READ MORE
Research and Technology

Historical Regulatory Use of RWE

April 14, 2020
Emma Mei

Historical uses of RWE in regulatory decision-making are at best sparse, but they provide the precedent on which we are building the foundation of real-world impact. This blog reviews use cases of RWE in regulatory actions.

READ MORE
Research and Technology

Managing COVID-19 Among Cancer Patients: Risk & Response

April 7, 2020
COTA Team

New research shows that cancer patients may be more susceptible to COVID-19 than individuals without cancer, and have poorer outcomes.

READ MORE
Research and Technology

COVID-19 & COTA: Perspectives from Mike Doyle, CEO

March 24, 2020
Mike Doyle

Reflecting on the weeks ahead as we try to prevent the spread of COVID-19, COTA's CEO Mike Doyle shares some of the things we’re doing to support our team members at COTA, and highlights promising industry developments.

READ MORE
Culture

COTA Team Member Spotlight: The Women of COTA

March 11, 2020
COTA Team

In honor of International Women's Day this month, we want to recognize the female colleagues who inspire us to work harder, collaborate more, and fiercely support each other.

READ MORE
Company News

COTA Appoints C.K. Wang, M.D. as New Chief Medical Officer

March 5, 2020
COTA Team

Dr. Wang’s Commitment to COTA’s Mission and Extensive Oncology Background Supports The Company’s Next Stage of Growth and Ongoing Partnerships

READ MORE
Culture

COTA Team Member Spotlight: Irfan Shah

February 10, 2020
COTA Team

For this month’s Team Member Spotlight, we are excited to introduce you to Irfan Shah! Irfan joined COTA in 2016 and is the company’s Director of Strategy and Business Development for life sciences.

READ MORE
Research and Technology

White Paper: Real-World Evidence Reflections and Predictions

January 31, 2020
COTA Team

Novel sources and growing volumes of data are changing the way drugs are developed, evaluated, and brought to market. In the spirit of collaboration, COTA invited our partners from Pfizer and Bristol-Myers Squibb to share their unique perspectives as early adopters of real-world evidence.

READ MORE
Company News

FierceHealthcare names COTA, Inc. as one of its 2020 “Fierce 15” Companies

January 13, 2020
COTA Team

COTA, Inc. has been named by FierceHealthcare as one of the 2020 Fierce 15 Companies, designating it as one of the most promising healthcare companies in the industry.

READ MORE
Company News

CEO Corner: COTA’s Year in Review

January 3, 2020
Mike Doyle

At COTA, 2019 represented a year of collaboration, research, and innovation to advance the use of real-world evidence in cancer care and drug development. As we think about what’s ahead in 2020, COTA's CEO Mike Doyle reflects on how activities this year set us up for future success and continued learning.

READ MORE
Culture

COTA Team Member Spotlight: Monica Matta

December 30, 2019
COTA Team

For this month’s Team Member Spotlight, we are excited to recognize Monica Matta, who was recently selected as the 2019 CO10 of the year! She brings passion and determination to COTA’s client relationships alongside her dedicated and growing team.

READ MORE
Research and Technology

Science, Innovation, and Survivorship: The Atlantic’s People v. Cancer

December 17, 2019
COTA Team

Last month, COTA participated in The Atlantic’s People v. Cancer, an annual event that brings together researchers, providers, patients and innovators to illuminate stories from the frontlines of the cancer community.

READ MORE
Company News

COTA and Guardant Health Collaborate Using Real-World Data to Reveal Insights into Metastatic Colon Cancer and Prevalence of Biomarker Testing

December 12, 2019
COTA Team

Research Published in JCO Precision Oncology Found Only 40 Percent of Patients with Metastatic Colon Cancer Receive Guideline-Recommended Biomarker Testing

READ MORE
Company News

COTA Presents Posters at ASH Annual Meeting, Reviewing Complexities of Generating RWD and How it Complements Traditional Clinical Trial Data

December 4, 2019
COTA Team

Research Presented Alongside MMRF and HUMC Evaluates Opportunity for RWE to Study Patient Treatment & Outcomes in Routine Cancer Care

READ MORE
Research and Technology

The Role of Data in Patient Care and Drug Development

November 25, 2019
Mike Doyle

This fall, COTA's CEO Mike Doyle attended the Healthcare Leaders Conference in Dallas, TX, and the Future of Health Data Summit 2019 in Washington, DC. In his conversations, a few key takeaways stood out around innovations related to the use of meaningful data...

READ MORE
Culture

COTA Team Member Spotlight: Tanvi Pal

November 22, 2019
COTA Team

We are pleased to recognize Tanvi Pal in this month’s Team Member Spotlight! If you’re interested in learning more about Tanvi, why she likes working at COTA and her thoughts on the future of cancer care, read on...

READ MORE
Research and Technology

How Real-World Evidence Can Validate TAILORx and Inform Cancer Care

October 22, 2019
CK Wang, MD

The TAILORx study was a major landmark in setting a new standard of care for breast cancer patients. But how well do real world treatment and outcomes mirror that of the clinical trial?

READ MORE
Mission

Video: #OurStoriesOurMission

October 17, 2019
COTA Team

During #BreastCancerAwarenessMonth, members of our team share their cancer stories and how these experiences inspire them to advance cancer care and research at COTA.

READ MORE
Research and Technology

Collaborating with our Frenemies

October 15, 2019
COTA Team

COTA’s medical and scientific teams recently participated in the 8th Annual Friends of Cancer Research Blueprint for Breakthrough Forum in Washington, DC with various stakeholders across the regulatory and RWE landscape.

READ MORE
Mission

Finding Support in Survivors’ Stories

October 11, 2019
Marquina Iliev-Piselli

While going through breast cancer treatment, Marquina Iliev-Piselli couldn’t find a book that provided the guidance & support she needed. So, she wrote her own. COTA recently connected with Marquina to learn about her diagnosis, journey, and what led her to becoming part of the support system for cancer patients.

READ MORE
Mission

#OurStoriesOurMission

October 2, 2019
COTA Team

While planning activities for breast cancer awareness month at COTA, Helena Yelovich who works on our medical team, made an impassioned request: “Don’t Ignore Stage 4.” Read more about her story on our blog.

READ MORE
Research and Technology

Summer Reading Recap: What you missed in oncology & healthcare

August 27, 2019
COTA Team

As summer is coming to a close and everyone is returning from their summer vacations, we wanted to take the opportunity to review some key moments in the news from the last few weeks.

READ MORE
Culture

COTA Team Member Spotlight: Maria Feinstein

August 22, 2019
COTA Team

We are pleased to recognize Maria Feinstein, MSN, RN, BMTCN in this month’s Team Member Spotlight! Learn more about Maria's background and her role at COTA in our latest blog.

READ MORE
Research and Technology

Initial Results of Real-World Evidence Pilot Study Published in JCO Clinical Cancer Informatics

August 6, 2019
COTA Team

Friends of Cancer Research collaborative project brings together COTA and nine other healthcare organizations & stakeholders to fuel understanding of RWE in oncology

READ MORE
Company News

COTA, Inc. Announces Headquarter Relocation to Boston for Continued Growth

August 1, 2019
COTA Team

COTA is relocating our headquarters to Boston! We are excited to immerse ourselves in a city that is rich in health technology and life science industries that align with our mission of improving cancer care.

READ MORE
Culture

Celebrating Diversity with COTA

July 30, 2019
COTA Team

Did you know COTA has a Diversity & Inclusion Committee to foster conversation, collaboration, and education between employees? Learn more about how this group recently celebrated National Celebrate Diversity Month and Pride Month, as well as COTA's support of the Title VII amicus brief.

READ MORE
Mission

Real World Cancer Stories

July 22, 2019
COTA Team

COTA hosts weekly lunch and learns where guests are invited to share their expertise or personal experiences on various topics. Recently, 35-year-old cancer survivor Tiffany Dyba joined a room full of CO10s at our NY office.

READ MORE
Company News

Behind the Brand: Unpacking Our New Look

July 8, 2019
COTA Team

If you’ve scrolled through our social channels or visited our website recently, you may have observed a different look and feel. Learn more about how our updated brand aligns with our company mission and values.

READ MORE
Culture

COTA Team Member Spotlight: Ashwin Lakshmanan

July 1, 2019
COTA Team

This month, we’re excited to recognize Ashwin Lakshmanan, Manager, Data Science and Analytics, in our latest Team Member Spotlight

READ MORE
Research and Technology

STAT+: How to Apply Real-World Evidence to Outsmart Cancer

June 25, 2019
COTA Team

Elaborating on the use cases for real-world data, Chris Boone, VP for global medical epidemiology & big data analysis at Pfizer, and Viraj Narayanan, VP of life sciences at COTA, Inc., recently co-authored a STAT+ article that explores how real-world evidence can be used to fuel precision medicine and disrupt increasingly outdated clinical trial models.

READ MORE
Research and Technology

ASCO 2019 - The Reaffirmation of Real-World Evidence in Cancer Care

June 13, 2019
Mike Doyle

The CO10s are back from ASCO 2019! See what Mike Doyle, COTA's CEO, took away from this year's conference as it relates to the use of real-world data and evidence in cancer care.

READ MORE
Company News

COTA News – Multiple Myeloma Research Foundation Launches CureCloud™ to Advance Precision Medicine

June 12, 2019
COTA Team

The MMRF announced they are launching CureCloud™, a centralized data hub that generates, aggregates and visualizes data to advance precision medicine to patients living with multiple myeloma. See how COTA is supporting this program!

READ MORE
Culture

COTA Team Member Spotlight: CC Obi-Gwacham

June 5, 2019
COTA Team

Learn more about CC Obi-Gwacham in the latest COTA Team Member Spotlight!

READ MORE
Company News

COTA Signs Research Collaboration Agreement With The U.S. Food and Drug Administration

May 29, 2019
COTA Team

Collaboration Aims to Study Variation in Cancer Treatment Patterns by Extracting and Analyzing Real-World Data

READ MORE
Research and Technology

ASCO 2019 - How Precision Medicine and RWE Can Shape the Future of Oncology Care

May 27, 2019
COTA Medical Leadership

In advance of the 2019 ASCO Annual Meeting, members of COTA's medical leadership team offer predictions for this year's conference on topics including the role of precision medicine and RWE in oncology care.

READ MORE
Culture

COTA Team Member Spotlight: Emily Di Capua

April 8, 2019
COTA Team

As a company that builds solutions that analyze real-world data to deliver clinically relevant insights that improve cancer care, we want to step back and feature the wonderful COTA team members (called CO10s) who are helping us achieve this goal. This week, we're featuring Emily Di Capua, our VP of Strategic Initiatives.

READ MORE
Research and Technology

The FDA’s History with RWE – and Continued Momentum from Dr. Sharpless

March 28, 2019
Mike Doyle

Earlier this month, Dr. Scott Gottlieb, the popular FDA Commissioner, announced he is resigning. COTA's blog explores what this means for the future of RWE and the FDA.

READ MORE
Culture

COTA Team Member Spotlight: Kaeleigh Farrish

March 12, 2019
COTA Team

As a company that builds solutions that analyze real-world data to deliver clinically relevant insights that improve cancer care, we want to step back and feature the wonderful COTA team members (called CO10s) who are helping us achieve this goal. The first CO10 that we are featuring in this spotlight series is Kaeleigh Farrish, COTA’s Director of Operations & Delivery Services!

READ MORE
Research and Technology

Reevaluating Expectations for HIT’s Biggest Bonanza

February 26, 2019
Mike Doyle

COTA's CEO Mike Doyle highlights his key takeaways from HIMSS19 around data stockpiling, thinking like consumers, and precision medicine.

READ MORE
Research and Technology

The Cancer Market is Booming – How Does That Impact Care?

February 7, 2019
Viraj Narayanan

It’s no secret that oncology care is at a turning point, but what does this mean for patient care? COTA's VP of Life Sciences Viraj Narayanan explores the impact and what we can expect in the future.

READ MORE
Research and Technology

Cancer Death Rate Hits 25 Years of Decline - What's Changing?

January 22, 2019
COTA Team

The American Cancer Society announced promising news to start off 2019 - the overall nationwide cancer death rate has fallen continuously over the last 25 years. What changes have led to this decline?

READ MORE
Research and Technology

HIMSS19: The Importance of Data and Managing Expectations

January 8, 2019
Mike Doyle

COTA's CEO Mike Doyle reflects on what to expect from HIMSS19. In healthcare, there is so much promise and opportunity for technology to deliver the best care possible, so how can we set the right expectations for new tech?

READ MORE
Research and Technology

What’s ahead in 2019? 4 Predictions from COTA’s Andrew Norden

December 27, 2018
Andrew Norden, M.D.

In today's dynamic healthcare environment, what can we expect in oncology in 2019? Dr. Andrew Norden, COTA's Chief Medical Officer, offers a few predictions to note in the fields of real-world evidence, cancer treatment, and clinical research.

READ MORE
Research and Technology

Changing How We Treat Cancer, Beginning with Drug Approvals

December 17, 2018
Andrew Norden, M.D.

Earlier this month, the FDA approved the drug Vitrakvi to treat a wide range of cancers. Andrew Norden, M.D., COTA's Chief Medical Officer, discusses what this means for the future of cancer care and precision medicine.

READ MORE
Company News

CEO Corner: Mike Doyle’s First Month at COTA

December 3, 2018
COTA Team

New CEO Mike Doyle reflects on his first month at COTA, the impact of precision medicine in oncology, and the clinical value of real world evidence.

READ MORE

COTA Increases Breakthrough Capability, adds Chief Technology Officer

October 15, 2018
COTA Team

READ MORE
Research and Technology

Meet Cota at ASCO's Annual Meeting and eyeforpharma's Oncology Market Access & Pricing Summit

May 31, 2017
COTA Team

Meet the Cota team as we hit the road to sponsor two major oncology events this summer.

READ MORE
Subscribe to receive the latest posts
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form

Bringing clarity
to cancer

We are working to ensure that everyone touched by cancer has a clear path to the right care.